Lucid-PSYCH

Lucid-PSYCH
Clinical data
Other namesLUCID-PSYCH; Lucid-201
Drug classUndefined; Psychedelic; Hallucinogen

Lucid-PSYCH, or LUCID-PSYCH, also known as Lucid-201, is a psychedelic hallucinogen which is under development for the treatment of major depressive disorder. It is under development by Lucid Psycheceuticals. Lucid-PSYCH's exact mechanism of action is undefined. As of March 2023, it is in preclinical research and is progressing to phase 1 clinical trials.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.